Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Baker Bros. Advisors Lp

Affiliations

  • Large Shareholder, Director at Neoleukin Therapeutics Inc. (NLTX), 2019-10-15
  • Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
  • Large Shareholder, Director at Incyte Corp (INCY), 2019-10-02
  • Large Shareholder, Director at Igm Biosciences Inc. (IGMS), 2019-09-20
  • Large Shareholder, Director at Acadia Pharmaceuticals Inc (ACAD), 2019-09-20
  • Large Shareholder, Director at Kodiak Sciences Inc. (KOD), 2019-09-20
  • Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
  • Large Shareholder at Atreca Inc. (BCEL), 2019-06-26
  • Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2019-06-07
  • Large Shareholder, Director at Kiniksa Pharmaceuticals Ltd. (KNSA), 2019-06-07
  • Large Shareholder, Director at Beigene Ltd. (BGNE), 2019-06-07
  • Director at Alexion Pharmaceuticals Inc. (ALXN), 2019-05-30
  • Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Large Shareholder at Invitae Corp (NVTA), 2018-03-29
  • Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2018-01-19
  • Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
  • Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
  • Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
  • Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
  • Other at Xoma Corp (XOMA), 2015-07-23
  • Other at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
IGMS $16.00 2,883,204 Large Shareholder, Director 2,883,204 2019-09-20 Filing
IGMS $16.00 260,796 Large Shareholder, Director 260,796 2019-09-20 Filing
ACAD $40.00 1,494,025 Large Shareholder, Director 37,470,965 2019-09-20 Filing
ACAD $40.00 68,475 Large Shareholder, Director 3,383,621 2019-09-20 Filing
AQXP $3.15 50,436 Large Shareholder, Director 10,105,159 2019-08-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXN $120.77 22,720 Director 7,382,978 2019-05-30 Filing
ALXN $120.77 2,729 Director 952,874 2019-05-30 Filing
ALXN $122.31 13,213 Director 7,405,698 2019-05-30 Filing
ALXN $122.31 1,587 Director 955,603 2019-05-30 Filing
ALXN $120.12 15,355 Director 7,418,911 2019-05-30 Filing